GlassScriptPhysician profile
Leah G Jacob
NPI 1902047988
$4,740.24
in general payments reported to CMS, 2019-2025
29 companies · $2,641 in 2025
The $2,641 reported for 2025 was more than what 82% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $495 · 2020: $41.19 · 2021: $70.71 · 2022: $127 · 2023: $73.98 · 2024: $1,292 · 2025: $2,641.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,850 · Education: $157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,849.97 |
| Education | $156.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $756.47 | 2019-2025 | |
| Janssen Biotech, INC. | $563.57 | 2019-2025 | Tremfya, Simponi Aria, Stelara |
| Lilly USA, LLC | $406.72 | 2019-2025 | Ebglyss, Taltz |
| Novartis Pharmaceuticals Corporation | $358.51 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $345.18 | 2019-2025 | Dupixent, Libtayo |
| Amgen INC. | $283.55 | 2019-2025 | Otezla, Otezla |
| E.R. Squibb & Sons, L.L.C. | $278.32 | 2023-2025 | Sotyktu |
| Ucb, INC. | $252.82 | 2019-2025 | Bimzelx |
| Pfizer INC. | $251.36 | 2024-2025 | |
| Genzyme Corporation | $223.71 | 2019-2025 | |
| Dermavant Sciences, INC. | $155.97 | 2024 | Vtama |
| Sun Pharmaceutical Industries INC. | $141.10 | 2020-2025 | |
| Leo Pharma INC. | $114.32 | 2020-2025 | Adbry, Anzupgo |
| Incyte Corporation | $85.62 | 2024-2025 | Opzelura |
| Mayne Pharma Commercial LLC | $56.93 | 2019-2025 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $52.54 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $47.37 | 2019-2025 | Siliq, Duobrii, Targretin |
| Elekta, INC. | $47.02 | 2025 | Flexitron Hdr |
| Arcutis Biotherapeutics, INC. | $43.69 | 2025 | Zoryve |
| Genentech USA, INC. | $42.42 | 2019 | |
| Paratek Pharmaceuticals, INC. | $36.64 | 2024-2025 | Nuzyra |
| Organon LLC | $36.55 | 2025 | Vtama, Hadlima |
| Galderma Laboratories, L.P. | $29.13 | 2025 | Nemluvio |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.18 | 2024 | Spevigo |
| Almirall LLC | $25.71 | 2025 | Seysara |
| Medimetriks Pharmaceuticals, INC. | $25.65 | 2025 | Genadur |
| Melinta Therapeutics, LLC | $18.06 | 2019 | |
| Botanix Sb INC | $17.17 | 2025 | Sofdra |
| Celgene Corporation | $16.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leah Jacob listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.